2005
DOI: 10.1148/radiol.2372041638
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Vascular Targeting Agent in Rat Tumor Model: Dynamic Contrast-enhanced versus Diffusion-weighted MR Imaging

Abstract: Both dynamic contrast-enhanced MR imaging and diffusion-weighted MR imaging allow monitoring of perfusion changes induced by vascular targeting agents in tumors. Diffusion-weighted imaging provides additional information about intratumoral cell viability versus necrosis after administration of combretastatin.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

8
96
1
6

Year Published

2009
2009
2016
2016

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 151 publications
(111 citation statements)
references
References 25 publications
8
96
1
6
Order By: Relevance
“…There was also substantial to excellent agreement regarding the evaluation of response at conventional MR imaging, DWI, and DCE imaging (k = 0.795, 0.840, and 0.773, respectively), and excellent agreement in the measurements of the ADCs (intraclass correlation coefficient, 0.8335; 95% confidence interval, 0.7729, 0.8791). response in soft-tissue sarcomas (20), although it can show tumor volume reduction from pretreatment imaging, as well as cystic regions presumed to be tumor necrosis (21,27,28 with alterations in tumor perfusion after neoadjuvant treatment, and ADCs are inversely related to tumor cellularity (17). Unlike DCE, DWI is a noncontrast technique and a potentially useful alternative for assessing response in patients with contraindications to the use of contrast material.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…There was also substantial to excellent agreement regarding the evaluation of response at conventional MR imaging, DWI, and DCE imaging (k = 0.795, 0.840, and 0.773, respectively), and excellent agreement in the measurements of the ADCs (intraclass correlation coefficient, 0.8335; 95% confidence interval, 0.7729, 0.8791). response in soft-tissue sarcomas (20), although it can show tumor volume reduction from pretreatment imaging, as well as cystic regions presumed to be tumor necrosis (21,27,28 with alterations in tumor perfusion after neoadjuvant treatment, and ADCs are inversely related to tumor cellularity (17). Unlike DCE, DWI is a noncontrast technique and a potentially useful alternative for assessing response in patients with contraindications to the use of contrast material.…”
Section: Discussionmentioning
confidence: 99%
“…Hence, the functional MR imaging techniques of DWI and DCE imaging may offer a more accurate assessment of histologic response, as suggested for other organ systems (9-13), and for osteosarcoma (5,6,(14)(15)(16). However, limited reports exist regarding the use of DWI (17)(18)(19) and DCE imaging for Abbreviations: ADC = apparent diffusion coefficient DCE = dynamic contrast enhanced DWI = diffusion-weighted imaging…”
Section: Study Populationmentioning
confidence: 99%
“…18 Because of the increased vascularity and cellularity of tumor tissues and in‰ammatory lesions, the contribution of intravascular water diŠusion may account for a signiˆcant proportion of the MR signal. 19,20 DWI is useful for detecting malignancies and evaluating their activity before and after treatment. 21 Like T 2 -weighted imaging, DWI may be valuable …”
Section: Dišusion-weighted Imaging For Detecting Andmentioning
confidence: 99%
“…Diffusion-weighted MRI (DW-MRI) has been used to image the tumor cell necrosis that results from a positive response to CA4P treatment, with a range of preclinical studies done in a rat rhabdomyosarcoma (13,14). In these studies, changes in apparent diffusion coefficient (ADC) were highly dependent on the timing of the DW-MRI measurements relative to the administration of the treatment.…”
Section: Introductionmentioning
confidence: 99%